Skip to main content

Pharma

By Nathan Eddy | 11:49 am | April 27, 2026
The pair will integrate real-time diagnostic data into marketing workflows, with the aim of helping pharmaceutical companies target clinicians at treatment decision moments.
By Jessica Hagen | 07:00 am | April 14, 2026
The company's agentic platform works to help pharmaceutical companies turn data into automated analyses, strategic insights and commercialization tools.
By Jessica Hagen | 02:00 am | April 14, 2026
The pharma giant will deploy OpenAI's most advanced capabilities across its global operations, from drug discovery to commercial functions, and upskill its workforce in AI literacy.
By Jessica Hagen | 12:58 pm | March 30, 2026
The deal grants Lilly exclusive global rights to use Insilico's Pharma.AI platform for drug discovery and development across multiple therapeutic areas.
By Jessica Hagen | 12:06 pm | March 17, 2026
The pharma giant’s AI factory combines on-premises and cloud GPU infrastructure, leveraging more than 3,500 Blackwell GPUs for AI-driven drug discovery and research.
By Susan Morse | 01:20 pm | February 23, 2026
Physicians tell Dr. Amy Bucher they feel a sense of empowerment in being able to offer patients something that, along with lifestyle changes, reduces weight, lowers the risk of diabetes and high blood pressure, and helps prevent other chronic conditions.
By Susan Morse | 01:55 pm | February 12, 2026
Amazon is competing with Walmart in the delivery business and against pharmacies such as CVS and Walgreens.
By Susan Morse | 01:03 pm | February 06, 2026
Patients can see the discounted prices on TrumpRx.gov, but the site does not currently sell the drugs.
By HIMSS TV | 09:46 am | January 23, 2026
AION Labs CEO, Mati Gill, discusses the company’s extensive backing from pharma and tech giants to build AI startups, and how AION is looking beyond AI to explore quantum technologies for research and development in drug discovery.
By Jessica Hagen | 12:05 pm | January 22, 2026
AION Labs CEO sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss the acquisition he says represents a milestone for Israel’s biotech ecosystem.